federal_register: 2024-14706
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-14706 | Excise Tax on Designated Drugs; Procedural Requirements | Rule | This document contains final regulations relating to the excise tax imposed on certain sales by manufacturers, producers, or importers of designated drugs. Specifically, the final regulations set forth procedural provisions relating to how taxpayers must report liability for such tax. The final regulations also except such tax from semimonthly deposit requirements. The final regulations affect manufacturers, producers, or importers of designated drugs dispensed, furnished, or administered to individuals under the terms of Medicare during certain statutory periods. | 2024-07-05 | 2024 | 7 | https://www.federalregister.gov/documents/2024/07/05/2024-14706/excise-tax-on-designated-drugs-procedural-requirements | https://www.govinfo.gov/content/pkg/FR-2024-07-05/pdf/2024-14706.pdf | Treasury Department; Internal Revenue Service | 497,254 | This document contains final regulations relating to the excise tax imposed on certain sales by manufacturers, producers, or importers of designated drugs. Specifically, the final regulations set forth procedural provisions relating to how taxpayers... | 1545-BQ93 |